We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Oxford University Reports COVID-19 Vaccine Induced More Antibodies in Early Trials as Two Full Doses
Oxford University Reports COVID-19 Vaccine Induced More Antibodies in Early Trials as Two Full Doses
Oxford University released new trial data last week that raises further questions about the most effective dosing regimen for Oxford’s COVID-19 vaccine candidate, AZD1222, that is being co-developed with AstraZeneca and how it came to pass that two different dosing regimens were pursued.